Author:
Sarashina Akiko,Sesoko Shogo,Nakashima Mitsuyoshi,Hayashi Naoyuki,Taniguchi Atsushi,Horie Yoshiharu,Graefe-Mody Eva U.,Woerle Hans-Juergen,Dugi Klaus A.
Subject
Pharmacology (medical),Pharmacology
Reference49 articles.
1. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030;Wild;Diabetes Care.,2004
2. Diagnosis and classification of diabetes mellitus;Diabetes Care.,2009
3. Diabetes trends in Japan;Kawamori;Diabetes Metab Res Rev.,2002
4. Diabetes in Japan;Hirose;Curr Diab Rep.,2005
5. Frequency of the atypical aldehyde dehydrogenase-2 gene (ALDH2(2)) in Japanese and Caucasians;Shibuya;Am J Hum Genet.,1988
Cited by
55 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Potential Role of Dipeptidyl Peptidase−4 in Regulating Mitochondria and Oxidative Stress in Cardiomyocytes;Cardiovascular Toxicology;2024-07-02
2. Unveiling Pharmacokinetics and Drug Interaction of Linagliptin and Pioglitazone HCl in Rat Plasma Using LC-MS/MS;Chemical Research in Toxicology;2024-04-29
3. Effect of Single Oral Coingestion of GABA and Malic Acid on Postprandial GLP‐1, Glucose, and Insulin Responses in Healthy Volunteers: A Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study;Molecular Nutrition & Food Research;2024-03-15
4. A Quantitative Systems Pharmacology Model of the Incretin Hormones GIP and GLP1, Glucagon, Glucose, Insulin, and the Small Molecule DPP-4 Inhibitor, Linagliptin;Journal of Pharmaceutical Sciences;2024-01
5. A model‐informed approach to accelerate the clinical development of cofrogliptin (HSK7653), a novel ultralong‐acting dipeptidyl peptidase‐4 inhibitor;Diabetes, Obesity and Metabolism;2023-11-12